Avicanna Completes First Delivery of Proprietary Topical Products to Multinational Pharmaceutical Company
Cosmetic registration and delivery into Germany completed in preparation for the initial commercial Launch TORONTO, Dec. 02, 2024 (GLOBE NEWSWIRE) — Avicanna Inc. (“Avicanna” or the “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a commercial stage, interna…
Author of the article:
Cosmetic registration and delivery into Germany completed in preparation for the initial commercial LaunchGNW
Article content
Cosmetic registration and delivery into Germany…